3 completed, 1 unknown. 3 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 2, Unknown 1 |
| Phase 1 | 1 | Completed 1 |
Follow telatinib: new trials by email Literature Review of telatinib trials Research Report on telatinib
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Efficacy of Telatinib in Combination With Keytruda in Subjects With Advanced Stomach and Gastroesophageal Junction Cancers or Hepatocellular Carcinoma Telatinib, Keytruda - Gastric Cancer, Hepatocellular Carcinoma | Phase 2 | Completed | Andrew Hendifar, MD | 16 | 2021-07-28 | 2025-12-11 |
| Telatinib in Combination With Capecitabine/ Oxaliplatin in 1st Line Gastric or GEJ Cancer Telatinib, Capecitabine, Oxaliplatin - Gastric Cancer | Phase 2 | Unknown | Taizhou EOC Pharma Co., Ltd. | 90 | 2019-01-25 | 2019-05-07 |
| Telatinib Safety and Pharmacokinetics Study in China Patients With Advanced Solid Tumors Telatinib Mesylate - Solid Tumor, Adult | Phase 1 | Completed | Taizhou EOC Pharma Co., Ltd. | 15 | 2017-07-25 | 2019-05-13 |
| A Study of Telatinib in Combination With Chemotherapy in Subjects With Advanced Gastric Cancer Cisplatin, Capecitabine, Telatinib - Gastric Cancer | Phase 2 | Completed | ACT Biotech, Inc | 48 | 2009-06-01 | 2012-02-08 |
Stomach Neoplasms (4) · Carcinoma, Hepatocellular (1)
Taizhou EOC Pharma Co., Ltd. (2) · ACT Biotech, Inc (1) · Andrew Hendifar, MD (1)
China (2) · United States (2) · Spain (1)
Andrew Hendifar, MD, MPH (1) · Jin Li, M.D. (1) · Scott Freeman, MD (1) · Tian Shu Liu, M.D. (1) · Tianshu Liu, MD (1)